| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Design Therapeutics, Inc.
13D/A
DSGN · 25056L103
|
10.7% |
3/11/2026
Event 3/9/2026
|
||||
| SR One Capital Fund I Aggregator, LP | 10.6% | |||||
| SR One Capital Partners I, LP | 10.6% | |||||
| SR One Capital Management, LLC | 10.6% | |||||
| Simeon George | 10.7% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.